The prognostic significance of stress hyperglycemia ratio for all-cause and cardiovascular mortality in metabolic syndrome patients: prospective cohort study

The prognostic significance of stress hyperglycemia ratio for all-cause and cardiovascular mortality in metabolic syndrome patients: prospective cohort study

The stress hyperglycemia ratio (SHR) is a new biomarker indicating acute hyperglycemia and predicting adverse outcomes in different conditions. Yet, its impact on metabolic syndrome (MetS) has not been studied. We explored the link between SHR and long-term all-cause and cardiovascular disease (CVD)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta diabetologica 2024-11
Hauptverfasser: Alifu, Jiasuer, Xu, Bin, Tuersun, Guliziba, Liu, Lu, Xiang, Lanqing, Mohammed, Abdul-Quddus, Zhang, Wen, Yin, Guoqing, Wang, Chunyue, Lv, Xian, Shi, Tingting, Wu, Qian, Abdu, Fuad A, Che, Wenliang
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Acta diabetologica
container_volume
creator Alifu, Jiasuer
Xu, Bin
Tuersun, Guliziba
Liu, Lu
Xiang, Lanqing
Mohammed, Abdul-Quddus
Zhang, Wen
Yin, Guoqing
Wang, Chunyue
Lv, Xian
Shi, Tingting
Wu, Qian
Abdu, Fuad A
Che, Wenliang
description The stress hyperglycemia ratio (SHR) is a new biomarker indicating acute hyperglycemia and predicting adverse outcomes in different conditions. Yet, its impact on metabolic syndrome (MetS) has not been studied. We explored the link between SHR and long-term all-cause and cardiovascular disease (CVD) mortality in MetS patients. We conducted a large prospective cohort study involving 9438 participants diagnosed with MetS, drawn from the 1999-2018 NHANES. MetS diagnosis was based on NCEP-ATPIII criteria. Participants were categorized into three groups based on SHR tertiles: T1 (SHR ≤ 0.890), T2 (SHR 0.890-0.992), and T3 (SHR ≥ 0.992). Cox regression and Kaplan-Meier curve analyses assessed the correlation between SHR and mortalities. Non-linear correlations were explored using restricted cubic splines, and stratification analysis was performed. Out of 9438 MetS patients, 1929 deaths occurred during an average follow-up of 107 ± 64 months, including 541 CVD deaths. All-cause and CVD mortality rates were significantly higher with elevated SHR values (T3) than lower tertiles (23.4% vs. 19.5% and 18.3%, P 
doi_str_mv 10.1007/s00592-024-02407-w
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3128318767</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3128318767</sourcerecordid><originalsourceid>FETCH-LOGICAL-c184t-991933d148db9e6934aa65d1edaf244367781caa120a389871229a626b724c253</originalsourceid><addsrcrecordid>eNpNkUtv1DAQxy0EoqXwBTggH7kE_EhimxuqykOqxKWcrVl7smvkxIvttMqH4bviZQviMJo5zP8h_Qh5zdk7zph6XxgbjOiY6E_DVPfwhFzyXopuEFI-_e--IC9K-cEYF0rq5-RCmoFpPQyX5NfdAekxp_2SSg2OlrBfwhQcLA5pmmipGUuhh-2IeR83h3MAmqGGRKeUKcTYOVgLUlg8dZB9SPdQ3Boh0znlCjHUjYaFzlhhl-IpYlt8TnOLbTa41PLhVKAc0dVwj9SlQ9O14NVvL8mzCWLBV4_7inz_dHN3_aW7_fb56_XH285x3dfOGG6k9LzXfmdwNLIHGAfP0cMk-l6OSmnuALhgILXRigthYBTjToneiUFekbdn31bk54ql2jkUhzHCgmktVnKhJddqVO1VnF9d61wyTvaYwwx5s5zZExZ7xmIbEvsHi31oojeP_utuRv9P8peD_A21tYyn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128318767</pqid></control><display><type>article</type><title>The prognostic significance of stress hyperglycemia ratio for all-cause and cardiovascular mortality in metabolic syndrome patients: prospective cohort study</title><source>Springer Nature - Complete Springer Journals</source><creator>Alifu, Jiasuer ; Xu, Bin ; Tuersun, Guliziba ; Liu, Lu ; Xiang, Lanqing ; Mohammed, Abdul-Quddus ; Zhang, Wen ; Yin, Guoqing ; Wang, Chunyue ; Lv, Xian ; Shi, Tingting ; Wu, Qian ; Abdu, Fuad A ; Che, Wenliang</creator><creatorcontrib>Alifu, Jiasuer ; Xu, Bin ; Tuersun, Guliziba ; Liu, Lu ; Xiang, Lanqing ; Mohammed, Abdul-Quddus ; Zhang, Wen ; Yin, Guoqing ; Wang, Chunyue ; Lv, Xian ; Shi, Tingting ; Wu, Qian ; Abdu, Fuad A ; Che, Wenliang</creatorcontrib><description>The stress hyperglycemia ratio (SHR) is a new biomarker indicating acute hyperglycemia and predicting adverse outcomes in different conditions. Yet, its impact on metabolic syndrome (MetS) has not been studied. We explored the link between SHR and long-term all-cause and cardiovascular disease (CVD) mortality in MetS patients. We conducted a large prospective cohort study involving 9438 participants diagnosed with MetS, drawn from the 1999-2018 NHANES. MetS diagnosis was based on NCEP-ATPIII criteria. Participants were categorized into three groups based on SHR tertiles: T1 (SHR ≤ 0.890), T2 (SHR 0.890-0.992), and T3 (SHR ≥ 0.992). Cox regression and Kaplan-Meier curve analyses assessed the correlation between SHR and mortalities. Non-linear correlations were explored using restricted cubic splines, and stratification analysis was performed. Out of 9438 MetS patients, 1929 deaths occurred during an average follow-up of 107 ± 64 months, including 541 CVD deaths. All-cause and CVD mortality rates were significantly higher with elevated SHR values (T3) than lower tertiles (23.4% vs. 19.5% and 18.3%, P &lt; 0.001; 6.8% vs. 5.3% and 5.1%, P = 0.007, respectively). A U-shaped relationship was observed between SHR and all-cause and CVD mortality (all P for non-linear &lt; 0.001). Kaplan-Meier analysis indicated higher SHR values associated with increased risk of all-cause and CVD mortality (all log-rank P &lt; 0.001). After adjusting for confounders, multivariate Cox regression showed SHR remained associated with a 1.256-fold and 1.023-fold risk of all-cause and CVD mortality. SHR independently correlates with all-cause and CVD mortality in MetS patients, displaying a U-shaped relationship with clinical endpoints.</description><identifier>ISSN: 1432-5233</identifier><identifier>EISSN: 1432-5233</identifier><identifier>DOI: 10.1007/s00592-024-02407-w</identifier><identifier>PMID: 39508855</identifier><language>eng</language><publisher>Germany</publisher><ispartof>Acta diabetologica, 2024-11</ispartof><rights>2024. Springer-Verlag Italia S.r.l., part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c184t-991933d148db9e6934aa65d1edaf244367781caa120a389871229a626b724c253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39508855$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alifu, Jiasuer</creatorcontrib><creatorcontrib>Xu, Bin</creatorcontrib><creatorcontrib>Tuersun, Guliziba</creatorcontrib><creatorcontrib>Liu, Lu</creatorcontrib><creatorcontrib>Xiang, Lanqing</creatorcontrib><creatorcontrib>Mohammed, Abdul-Quddus</creatorcontrib><creatorcontrib>Zhang, Wen</creatorcontrib><creatorcontrib>Yin, Guoqing</creatorcontrib><creatorcontrib>Wang, Chunyue</creatorcontrib><creatorcontrib>Lv, Xian</creatorcontrib><creatorcontrib>Shi, Tingting</creatorcontrib><creatorcontrib>Wu, Qian</creatorcontrib><creatorcontrib>Abdu, Fuad A</creatorcontrib><creatorcontrib>Che, Wenliang</creatorcontrib><title>The prognostic significance of stress hyperglycemia ratio for all-cause and cardiovascular mortality in metabolic syndrome patients: prospective cohort study</title><title>Acta diabetologica</title><addtitle>Acta Diabetol</addtitle><description>The stress hyperglycemia ratio (SHR) is a new biomarker indicating acute hyperglycemia and predicting adverse outcomes in different conditions. Yet, its impact on metabolic syndrome (MetS) has not been studied. We explored the link between SHR and long-term all-cause and cardiovascular disease (CVD) mortality in MetS patients. We conducted a large prospective cohort study involving 9438 participants diagnosed with MetS, drawn from the 1999-2018 NHANES. MetS diagnosis was based on NCEP-ATPIII criteria. Participants were categorized into three groups based on SHR tertiles: T1 (SHR ≤ 0.890), T2 (SHR 0.890-0.992), and T3 (SHR ≥ 0.992). Cox regression and Kaplan-Meier curve analyses assessed the correlation between SHR and mortalities. Non-linear correlations were explored using restricted cubic splines, and stratification analysis was performed. Out of 9438 MetS patients, 1929 deaths occurred during an average follow-up of 107 ± 64 months, including 541 CVD deaths. All-cause and CVD mortality rates were significantly higher with elevated SHR values (T3) than lower tertiles (23.4% vs. 19.5% and 18.3%, P &lt; 0.001; 6.8% vs. 5.3% and 5.1%, P = 0.007, respectively). A U-shaped relationship was observed between SHR and all-cause and CVD mortality (all P for non-linear &lt; 0.001). Kaplan-Meier analysis indicated higher SHR values associated with increased risk of all-cause and CVD mortality (all log-rank P &lt; 0.001). After adjusting for confounders, multivariate Cox regression showed SHR remained associated with a 1.256-fold and 1.023-fold risk of all-cause and CVD mortality. SHR independently correlates with all-cause and CVD mortality in MetS patients, displaying a U-shaped relationship with clinical endpoints.</description><issn>1432-5233</issn><issn>1432-5233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkUtv1DAQxy0EoqXwBTggH7kE_EhimxuqykOqxKWcrVl7smvkxIvttMqH4bviZQviMJo5zP8h_Qh5zdk7zph6XxgbjOiY6E_DVPfwhFzyXopuEFI-_e--IC9K-cEYF0rq5-RCmoFpPQyX5NfdAekxp_2SSg2OlrBfwhQcLA5pmmipGUuhh-2IeR83h3MAmqGGRKeUKcTYOVgLUlg8dZB9SPdQ3Boh0znlCjHUjYaFzlhhl-IpYlt8TnOLbTa41PLhVKAc0dVwj9SlQ9O14NVvL8mzCWLBV4_7inz_dHN3_aW7_fb56_XH285x3dfOGG6k9LzXfmdwNLIHGAfP0cMk-l6OSmnuALhgILXRigthYBTjToneiUFekbdn31bk54ql2jkUhzHCgmktVnKhJddqVO1VnF9d61wyTvaYwwx5s5zZExZ7xmIbEvsHi31oojeP_utuRv9P8peD_A21tYyn</recordid><startdate>20241107</startdate><enddate>20241107</enddate><creator>Alifu, Jiasuer</creator><creator>Xu, Bin</creator><creator>Tuersun, Guliziba</creator><creator>Liu, Lu</creator><creator>Xiang, Lanqing</creator><creator>Mohammed, Abdul-Quddus</creator><creator>Zhang, Wen</creator><creator>Yin, Guoqing</creator><creator>Wang, Chunyue</creator><creator>Lv, Xian</creator><creator>Shi, Tingting</creator><creator>Wu, Qian</creator><creator>Abdu, Fuad A</creator><creator>Che, Wenliang</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20241107</creationdate><title>The prognostic significance of stress hyperglycemia ratio for all-cause and cardiovascular mortality in metabolic syndrome patients: prospective cohort study</title><author>Alifu, Jiasuer ; Xu, Bin ; Tuersun, Guliziba ; Liu, Lu ; Xiang, Lanqing ; Mohammed, Abdul-Quddus ; Zhang, Wen ; Yin, Guoqing ; Wang, Chunyue ; Lv, Xian ; Shi, Tingting ; Wu, Qian ; Abdu, Fuad A ; Che, Wenliang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c184t-991933d148db9e6934aa65d1edaf244367781caa120a389871229a626b724c253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alifu, Jiasuer</creatorcontrib><creatorcontrib>Xu, Bin</creatorcontrib><creatorcontrib>Tuersun, Guliziba</creatorcontrib><creatorcontrib>Liu, Lu</creatorcontrib><creatorcontrib>Xiang, Lanqing</creatorcontrib><creatorcontrib>Mohammed, Abdul-Quddus</creatorcontrib><creatorcontrib>Zhang, Wen</creatorcontrib><creatorcontrib>Yin, Guoqing</creatorcontrib><creatorcontrib>Wang, Chunyue</creatorcontrib><creatorcontrib>Lv, Xian</creatorcontrib><creatorcontrib>Shi, Tingting</creatorcontrib><creatorcontrib>Wu, Qian</creatorcontrib><creatorcontrib>Abdu, Fuad A</creatorcontrib><creatorcontrib>Che, Wenliang</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta diabetologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alifu, Jiasuer</au><au>Xu, Bin</au><au>Tuersun, Guliziba</au><au>Liu, Lu</au><au>Xiang, Lanqing</au><au>Mohammed, Abdul-Quddus</au><au>Zhang, Wen</au><au>Yin, Guoqing</au><au>Wang, Chunyue</au><au>Lv, Xian</au><au>Shi, Tingting</au><au>Wu, Qian</au><au>Abdu, Fuad A</au><au>Che, Wenliang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prognostic significance of stress hyperglycemia ratio for all-cause and cardiovascular mortality in metabolic syndrome patients: prospective cohort study</atitle><jtitle>Acta diabetologica</jtitle><addtitle>Acta Diabetol</addtitle><date>2024-11-07</date><risdate>2024</risdate><issn>1432-5233</issn><eissn>1432-5233</eissn><abstract>The stress hyperglycemia ratio (SHR) is a new biomarker indicating acute hyperglycemia and predicting adverse outcomes in different conditions. Yet, its impact on metabolic syndrome (MetS) has not been studied. We explored the link between SHR and long-term all-cause and cardiovascular disease (CVD) mortality in MetS patients. We conducted a large prospective cohort study involving 9438 participants diagnosed with MetS, drawn from the 1999-2018 NHANES. MetS diagnosis was based on NCEP-ATPIII criteria. Participants were categorized into three groups based on SHR tertiles: T1 (SHR ≤ 0.890), T2 (SHR 0.890-0.992), and T3 (SHR ≥ 0.992). Cox regression and Kaplan-Meier curve analyses assessed the correlation between SHR and mortalities. Non-linear correlations were explored using restricted cubic splines, and stratification analysis was performed. Out of 9438 MetS patients, 1929 deaths occurred during an average follow-up of 107 ± 64 months, including 541 CVD deaths. All-cause and CVD mortality rates were significantly higher with elevated SHR values (T3) than lower tertiles (23.4% vs. 19.5% and 18.3%, P &lt; 0.001; 6.8% vs. 5.3% and 5.1%, P = 0.007, respectively). A U-shaped relationship was observed between SHR and all-cause and CVD mortality (all P for non-linear &lt; 0.001). Kaplan-Meier analysis indicated higher SHR values associated with increased risk of all-cause and CVD mortality (all log-rank P &lt; 0.001). After adjusting for confounders, multivariate Cox regression showed SHR remained associated with a 1.256-fold and 1.023-fold risk of all-cause and CVD mortality. SHR independently correlates with all-cause and CVD mortality in MetS patients, displaying a U-shaped relationship with clinical endpoints.</abstract><cop>Germany</cop><pmid>39508855</pmid><doi>10.1007/s00592-024-02407-w</doi></addata></record>
fulltext fulltext
identifier ISSN: 1432-5233
ispartof Acta diabetologica, 2024-11
issn 1432-5233
1432-5233
language eng
recordid cdi_proquest_miscellaneous_3128318767
source Springer Nature - Complete Springer Journals
title The prognostic significance of stress hyperglycemia ratio for all-cause and cardiovascular mortality in metabolic syndrome patients: prospective cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A12%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prognostic%20significance%20of%20stress%20hyperglycemia%20ratio%20for%20all-cause%20and%20cardiovascular%20mortality%20in%20metabolic%20syndrome%20patients:%20prospective%20cohort%20study&rft.jtitle=Acta%20diabetologica&rft.au=Alifu,%20Jiasuer&rft.date=2024-11-07&rft.issn=1432-5233&rft.eissn=1432-5233&rft_id=info:doi/10.1007/s00592-024-02407-w&rft_dat=%3Cproquest_cross%3E3128318767%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3128318767&rft_id=info:pmid/39508855&rfr_iscdi=true